Vanguard Group »

Bicara Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Bicara Therapeutics (BCAX) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Bicara Therapeutics

Oct 62024Oct 20Nov 3Nov 17Dec 1Dec 15Dec 295M10M15M20M00.5M1M
Value ($)Share countHistorical BCAX position of Vanguard Group Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Bicara Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicara Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $19M 1.1M 17.42
2024-09-30 $1.8M 70k 25.47

More positions owned by Vanguard Group

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Exxon Mobil Corporation (XOM)
UnitedHealth (UNH)

View all positions for Vanguard Group

Top funds holding Bicara Therapeutics

RA Capital Management
Siren
Tpg Gp A
Omega Fund Management
Adage Capital Partners GP
FMR
Braidwell
Deerfield Management Company
T. Rowe Price Associates
Fairmount Funds Management
BlackRock
Vanguard Group
Fil
Blackstone Group
Henderson Group

View all funds holding Bicara Therapeutics